(Total Views: 295)
Posted On: 02/03/2021 9:57:08 AM
Post# of 36564
Ok here is the relevant info from the release in Nov:
$50 million licensing deal for the Ii-Key platform to develop vaccines for infectiousdiseases and cancer
− Deal includes first contract for Ii-Key- SARS-CoV-2 vaccine against COVID-19 in Chinawith a $5 million upfront licensing fee, 100% funding for manufacturing, development and commercial registration and a $20 million success fee for approval Ii-Key- SARSCoV-2 vaccine in China
Here is most recent PR:
- China Licensing & Research Agreement advances with $100,000
payment guarantee and $1 million advance on development funding
So my interpretation. We've received the $100k. This $1m is not part of the $5m advance on licensing but part of the "100% funding for manufacturing, development and commercial registration "
I see this as bullish. My initial take was negative.
Still disappointed not to see any reference to IPO
$50 million licensing deal for the Ii-Key platform to develop vaccines for infectiousdiseases and cancer
− Deal includes first contract for Ii-Key- SARS-CoV-2 vaccine against COVID-19 in Chinawith a $5 million upfront licensing fee, 100% funding for manufacturing, development and commercial registration and a $20 million success fee for approval Ii-Key- SARSCoV-2 vaccine in China
Here is most recent PR:
- China Licensing & Research Agreement advances with $100,000
payment guarantee and $1 million advance on development funding
So my interpretation. We've received the $100k. This $1m is not part of the $5m advance on licensing but part of the "100% funding for manufacturing, development and commercial registration "
I see this as bullish. My initial take was negative.
Still disappointed not to see any reference to IPO
(3)
(0)
